ALEXANDRIA MOLARO: Open Payments
NPI 1184213829 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,012 in 106 payments from 23 companies in 2025. Trend: 2023 $1,310 · 2024 $1,578 · 2025 $2,012
Food & beverage: $1,942Education: $70
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 17 | $384 |
| Amgen Inc. | 7 | $239 |
| Novo Nordisk Inc | 16 | $223 |
| ABBVIE INC. | 13 | $195 |
| RECORDATI_RARE_DISEASES_INC. | 12 | $174 |
| Bausch Health US, LLC | 6 | $101 |
| HARMONY BIOSCIENCES LLC | 2 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| PFIZER INC. | 3 | $70 |
| Lilly USA, LLC | 4 | $59 |
Products named: Korlym, REPATHA, ISTURISA, APLENZIN, TRINTELLIX, Wegovy, NURTEC ODT, QULIPTA.
Industry payments across IN — which companies pay providers there.
